158 related articles for article (PubMed ID: 34365012)
21. Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.
Bacher U; Shumilov E; Flach J; Porret N; Joncourt R; Wiedemann G; Fiedler M; Novak U; Amstutz U; Pabst T
Blood Cancer J; 2018 Nov; 8(11):113. PubMed ID: 30420667
[TBL] [Abstract][Full Text] [Related]
22. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
Kohlmann A; Bacher U; Schnittger S; Haferlach T
Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
[TBL] [Abstract][Full Text] [Related]
23. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Fernandez-Mercado M; Burns A; Pellagatti A; Giagounidis A; Germing U; Agirre X; Prosper F; Aul C; Killick S; Wainscoat JS; Schuh A; Boultwood J
Haematologica; 2013 Dec; 98(12):1856-64. PubMed ID: 23831921
[TBL] [Abstract][Full Text] [Related]
24. Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.
Maes B; Willemse J; Broekmans A; Smets R; Cruys B; Put N; Madoe V; Janssen M; Soepenberg O; Bries G; Vrelust I; Achten R; Van Pelt K; Buvé K; Theunissen K; Peeters V; Froyen G
Int J Lab Hematol; 2017 Dec; 39(6):604-612. PubMed ID: 28722833
[TBL] [Abstract][Full Text] [Related]
25. A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients.
Prieto-Conde MI; Corchete LA; García-Álvarez M; Jiménez C; Medina A; Balanzategui A; Hernández-Ruano M; Maldonado R; Sarasquete ME; Alcoceba M; Puig N; González-Calle V; García-Sanz R; Gutiérrez NC; González-Díaz M; Chillón MC
J Mol Diagn; 2020 Jan; 22(1):60-71. PubMed ID: 31605801
[TBL] [Abstract][Full Text] [Related]
26. Clinical Evaluation of a Novel Nine-Gene Panel for Ion Torrent PGM Sequencing of Myeloid Malignancies.
Ivanova M; Shivarov V; Pavlov I; Lilakos K; Naumova E
Mol Diagn Ther; 2016 Feb; 20(1):27-32. PubMed ID: 26476543
[TBL] [Abstract][Full Text] [Related]
27. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
Gillis NK; Ball M; Zhang Q; Ma Z; Zhao Y; Yoder SJ; Balasis ME; Mesa TE; Sallman DA; Lancet JE; Komrokji RS; List AF; McLeod HL; Alsina M; Baz R; Shain KH; Rollison DE; Padron E
Lancet Oncol; 2017 Jan; 18(1):112-121. PubMed ID: 27927582
[TBL] [Abstract][Full Text] [Related]
28. Next generation sequencing in therapy-related myeloid neoplasms compared to
Claerhout H; Vranckx H; Lierman E; Michaux L; Boeckx N
Acta Clin Belg; 2022 Jun; 77(3):658-663. PubMed ID: 34197279
[TBL] [Abstract][Full Text] [Related]
29. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
30. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
31. Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.
Pietka G; De Lord C; Matthias G; Cheung B; Atwal S; Furtado M; Cullis J; Grey-Davies L; Narayanan S; McGregor A; Kilner M; Bosworth J; McMullin MF; Coats T; Parcharidou A; Cavenagh J; Byrne J; Iyengar S; Mohammed K; Cross N; Hubank M; Ribeiro S; Khorashad J; Wren D; O'Connor S; Taussig D
Br J Haematol; 2024 Apr; 204(4):1325-1334. PubMed ID: 38462984
[TBL] [Abstract][Full Text] [Related]
32. Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data.
Cheng DT; Cheng J; Mitchell TN; Syed A; Zehir A; Mensah NYT; Oultache A; Nafa K; Levine RL; Arcila ME; Berger MF; Hedvat CV
J Mol Diagn; 2014 Sep; 16(5):504-518. PubMed ID: 25017477
[TBL] [Abstract][Full Text] [Related]
33. Mutation in TET2 in myeloid cancers.
Delhommeau F; Dupont S; Della Valle V; James C; Trannoy S; Massé A; Kosmider O; Le Couedic JP; Robert F; Alberdi A; Lécluse Y; Plo I; Dreyfus FJ; Marzac C; Casadevall N; Lacombe C; Romana SP; Dessen P; Soulier J; Viguié F; Fontenay M; Vainchenker W; Bernard OA
N Engl J Med; 2009 May; 360(22):2289-301. PubMed ID: 19474426
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.
Euba B; Vizmanos JL; García-Granero M; Aranaz P; Hurtado C; Migueliz I; Novo FJ; García-Delgado M
Leuk Lymphoma; 2012 Jun; 53(6):1230-3. PubMed ID: 22080757
[No Abstract] [Full Text] [Related]
35. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
Bacher U; Weissmann S; Kohlmann A; Schindela S; Alpermann T; Schnittger S; Kern W; Haferlach T; Haferlach C
Br J Haematol; 2012 Jan; 156(1):67-75. PubMed ID: 22017486
[TBL] [Abstract][Full Text] [Related]
36. Identifying large indels in targeted next generation sequencing assays for myeloid neoplasms: a cautionary tale of the
Ng IK; Ng C; Low JJ; Chiu L; Seah E; Ng CH; Chng WJ; Yan B; Ban KHK
J Clin Pathol; 2017 Dec; 70(12):1069-1073. PubMed ID: 28676493
[TBL] [Abstract][Full Text] [Related]
37. Recurrent genetic defects on chromosome 5q in myeloid neoplasms.
Hosono N; Makishima H; Mahfouz R; Przychodzen B; Yoshida K; Jerez A; LaFramboise T; Polprasert C; Clemente MJ; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Sanada M; Cui E; Verma AK; McDevitt MA; List AF; Saunthararajah Y; Sekeres MA; Boultwood J; Ogawa S; Maciejewski JP
Oncotarget; 2017 Jan; 8(4):6483-6495. PubMed ID: 28031539
[TBL] [Abstract][Full Text] [Related]
38. RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.
Shanmuganathan N; Wadham C; Thomson D; Shahrin NH; Vignaud C; Obourn V; Chaturvedi S; Yang F; Feng J; Saunders V; Kok CH; Yeung D; King RM; Kenyon RR; Lin M; Wang P; Scott H; Hughes T; Schreiber AW; Branford S
J Mol Diagn; 2022 Jul; 24(7):803-822. PubMed ID: 35550185
[TBL] [Abstract][Full Text] [Related]
39. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
Asada S; Kitamura T
Int J Hematol; 2019 Aug; 110(2):179-186. PubMed ID: 30515738
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
Patel U; Luthra R; Medeiros LJ; Patel KP
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
